Loading data for CANF — first visit, this takes a few seconds.

Can-Fite BioPharma Ltd. (CANF)

NYSE American: CANF · 实时价格 · USD

2.22

+0.06 (2.78%)

收盘价： Sep 10, 2026, 8:00 PM

2.17

+0.46%

盘前: 5:02 AM

提醒

Alert

股价、关键数字和最新消息，都在这一页。

暂无数据

买价	2.17
市值	4.63M
营收（TTM）	405K
净利润（TTM）	-9.83M
	-0.04
	-4.58
	n/a
	-8
市净率（TTM）	1.01
市销率（TTM）	11.43
财报日期	Mar 27, 2020

卖价	2.28
成交量	12,020
20日均量	1,773,341
开盘价	2.17
前收盘价	2.16
日内区间	2.16 - 2.28
52周区间	2.16 - 13.40
分析师	n/a
目标价	n/a
分红	n/a
除息日	n/a

关于 CANF

Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops orally bioavailable small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction in Israel. The company's lead drug candidate Piclidenoson, which has been completed Phase III clinical trial for the treatment of psoriasis. It develops Namodenoson that is in Phase III clinical trial for the treatment of liver cance...

[阅读更多]

行业 Biotechnology

板块 Healthcare

上市日期 Nov 6, 2012

员工人数 5

交易所 NYSE American

股票代码 CANF

官网 https://www.canfite.com

公司完整简介

财务表现

2025年，Can-Fite BioPharma的营收为405K，较上一年的674K下降-39.91%。净利润为-9.83M，增长24.72%。

财务报表

财报意外

Can-Fite BioPharma 已于 Mar 28, 2024 发布季度财报：

营收为 n/a 低于预期 $0, ， NaN% 同比增长.
每股收益为 -60 低于预期 -52.60, ， 0.00% 同比增长.

下次财报发布时间

Can-Fite BioPharma Ltd. 的下次财报预计于 Mar 27, 2020, 开盘前。
分析师预计营收为 ... 升级

股价变动原因

新闻

2月前 · MT Newswires

Sector Update: Healthcare Stocks Higher Late Afternoon

Healthcare stocks were higher late Wednesday afternoon, with the NYSE Healthcare Index up 0.1% and t

6月前 · Zacks

CANF Stock Soars 20% on Positive Mid-Stage Pancreatic Cancer Data

Can-Fite stock jumps 20% after mid-stage data show namodenoson is well tolerated in advanced pancreatic cancer patients, meeting the study's primary safety endpoint.

8月前 · MT Newswires

Sector Update: Health Care Stocks Edge Higher Late Afternoon

Health care stocks were edging up late Friday afternoon with the NYSE Health Care Index and the Stat

8月前 · MT Newswires

Sector Update: Health Care Stocks Lower in Friday Afternoon Trading

Health care stocks declined Friday afternoon, with the NYSE Health Care Index and the State Street H

8月前 · MT Newswires

Top Midday Stories: Nvidia-Groq Licensing Deal; Target Attracts Growing Interest From Toms Capital

All three major US stock indexes were edging lower in midday trading on Friday following the Christm

第 1 页，共 2 页

Can-Fite BioPharma Ltd. (CANF)